Cargando…

The Evidence Base For Psychiatric Support For Living Independently And Being Included In The Community

Functional recovery of subjects with schizophrenia remains an unmet need despite the availability of effective pharmacological and psychosocial treatments. The focus of recovery-oriented approaches is on fostering hope and resilience, fighting self-stigma, supporting self-determination and promoting...

Descripción completa

Detalles Bibliográficos
Autor principal: Mucci, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565702/
http://dx.doi.org/10.1192/j.eurpsy.2022.61
_version_ 1784808955566882816
author Mucci, A.
author_facet Mucci, A.
author_sort Mucci, A.
collection PubMed
description Functional recovery of subjects with schizophrenia remains an unmet need despite the availability of effective pharmacological and psychosocial treatments. The focus of recovery-oriented approaches is on fostering hope and resilience, fighting self-stigma, supporting self-determination and promoting social inclusion. The implementation of recovery-oriented plans requires an in depth understanding of key factors influencing real-life functioning, health status and quality of life. Recently published data from the Italian Network for Research on Psychoses have provided evidence that baseline variables associated with functional outcome at follow-up included domains not routinely assessed and targeted by intervention programs in community mental health services. As pointed out by experts in schizophrenia research and care, the management of subjects with schizophrenia has not significantly improved and only a minority of them receives integrated and personalized treatments. Shared decision-making and integrated pharmacological and psychosocial treatments, tailored on subjects’ needs, might significantly improve the outcome of subjects with schizophrenia, supporting independent living and inclusion in the community. DISCLOSURE: Honoraria, advisory board, or consulting fees from Angelini, Astra Zeneca, Bristol-Myers Squibb, Gedeon Richter Bulgaria, Innova-Pharma, Janssen Pharmaceuticals, Lundbeck, Otsuka, Pfizer, and Pierre Fabre, for services not related to this abstract
format Online
Article
Text
id pubmed-9565702
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95657022022-10-17 The Evidence Base For Psychiatric Support For Living Independently And Being Included In The Community Mucci, A. Eur Psychiatry Mental Health Policy Functional recovery of subjects with schizophrenia remains an unmet need despite the availability of effective pharmacological and psychosocial treatments. The focus of recovery-oriented approaches is on fostering hope and resilience, fighting self-stigma, supporting self-determination and promoting social inclusion. The implementation of recovery-oriented plans requires an in depth understanding of key factors influencing real-life functioning, health status and quality of life. Recently published data from the Italian Network for Research on Psychoses have provided evidence that baseline variables associated with functional outcome at follow-up included domains not routinely assessed and targeted by intervention programs in community mental health services. As pointed out by experts in schizophrenia research and care, the management of subjects with schizophrenia has not significantly improved and only a minority of them receives integrated and personalized treatments. Shared decision-making and integrated pharmacological and psychosocial treatments, tailored on subjects’ needs, might significantly improve the outcome of subjects with schizophrenia, supporting independent living and inclusion in the community. DISCLOSURE: Honoraria, advisory board, or consulting fees from Angelini, Astra Zeneca, Bristol-Myers Squibb, Gedeon Richter Bulgaria, Innova-Pharma, Janssen Pharmaceuticals, Lundbeck, Otsuka, Pfizer, and Pierre Fabre, for services not related to this abstract Cambridge University Press 2022-09-01 /pmc/articles/PMC9565702/ http://dx.doi.org/10.1192/j.eurpsy.2022.61 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Mental Health Policy
Mucci, A.
The Evidence Base For Psychiatric Support For Living Independently And Being Included In The Community
title The Evidence Base For Psychiatric Support For Living Independently And Being Included In The Community
title_full The Evidence Base For Psychiatric Support For Living Independently And Being Included In The Community
title_fullStr The Evidence Base For Psychiatric Support For Living Independently And Being Included In The Community
title_full_unstemmed The Evidence Base For Psychiatric Support For Living Independently And Being Included In The Community
title_short The Evidence Base For Psychiatric Support For Living Independently And Being Included In The Community
title_sort evidence base for psychiatric support for living independently and being included in the community
topic Mental Health Policy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565702/
http://dx.doi.org/10.1192/j.eurpsy.2022.61
work_keys_str_mv AT muccia theevidencebaseforpsychiatricsupportforlivingindependentlyandbeingincludedinthecommunity
AT muccia evidencebaseforpsychiatricsupportforlivingindependentlyandbeingincludedinthecommunity